JSC
ELV icon

Jackson Square Capital’s Elevance Health ELV Stock Holding History

Jackson Square Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-694
Closed -$319K – 119
2023
Q1 		$319K Hold
694
– – 0.14% 91
2022
Q4 		$356K Sell
694
-62
-8% -$31.5K 0.17% 98
2022
Q3 		$343K Sell
756
-25
-3% -$12K 0.17% 98
2022
Q2 		$377K Buy
+781
New +$386K 0.16% 90

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jackson Square Capital's ELV Position: Q2 2023 in Review

Jackson Square Capital sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 694 shares — an estimated $319K sold.

Jackson Square Capital first reported a position in ELV in Q2 2022 and held it in 4 quarters. The position peaked at $377K in Q2 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Jackson Square Capital reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Jackson Square Capital sold 694 Elevance Health shares in Q2 2023, an estimated $319K.
  • Jackson Square Capital first reported a position in Elevance Health in Q2 2022 and held it in 4 quarters.
  • Jackson Square Capital's Elevance Health position peaked at $377K in Q2 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Jackson Square Capital's 13F filing for Q2 2023, filed 28 Jul 2023.